Comparison of clinical features, CD4 and CD8 responses among patients with acute HIV-1 infection from Geneva, Seattle and Sydney

AIDS

Volumn 14, Issue 4, 2000, Pages 375-381

  Vanhems, Philippe ^a,b   Hughes, Jim ^b   Collier, Ann C ^c   Vizzard, Jeanette ^d   Perrin, Luc ^e   Cooper, David A ^d   Hirschel, Bernard ^e   Corey, Lawrence ^f  

^a UNIVERSITÉ LYON 1   (France)

^b Center for AIDS and STD   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e UNIVERSITY HOSPITAL   (Switzerland)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Acute infection; Cohort studies; Diagnosis; HIV 1

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ARTHRALGIA; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETHARGY; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; MYALGIA; PHARYNGITIS; PRIORITY JOURNAL; RASH; SEROCONVERSION; STATISTICAL ANALYSIS; SYMPTOM;

CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; HIV INFECTIONS; HIV-1; HUMANS; PLACEBOS; T-LYMPHOCYTE SUBSETS;

EID: 0034068406     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200003100-00010     Document Type: Article

References (25)

1. 1. Mussey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficieciency virus type 1 infection. N Engl J Med 1997, 337:1267-1274.
2. 2. Schacker TW, Hughes JP, Shea T, Coombs RW, Corey L. Biological and virological characteristics of primary HIV infection. Ann Intern Med 1998, 128:613-620.
3. 3. Pedersen C, Lindhart BO, Jensen BL, et al. Clinical course of primary HIV infection: consequences for subsequent course of infection, Br Med J 1989, 299:154-157.
4. 4. Vanhems P, Lambert J, Cooper DA, et al. Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose response relationship. Clin Infect Dis 1998, 26:323-329.
5. 5. Jacquez JA, Koopman JS, Simon CP, Longini IM. Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immune Defic Syndr 1994, 7:1169-1184.
6. 6. Vanhems P, Allard R, Cooper DA, et al. Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? Clin Infect Dis 1997, 24:965-970.
7. 7. Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996, 125:257-264.
8. 8. Ledergeber B, von Overbeck J, Egger M, Luthy R. The Swiss HIV cohort study: rationale, organization and selected baseline characteristics. Sozial- und Praventivmedizin 1994, 39:387-394.
9. 9. Kinloch-de Loës S, Hirschel BJ, Hoen B, et al. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med 1995, 333:408-413.
10. 10. Tindall B, Barker S, Donovan B, et al. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med 1988, 148:945-949.
11. 11. Centers for Disease Control. Guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus infection. MMWR 1992, 1(RR-8):1-17.
12. 12. Kagan J, Gelman R, Waxdal M, Kidd P. NIAID Division of AIDS flow cytometry quality assessment program. Ann N Y Acad Sci, 1993, 677:50-52.
13. 13. Laird N, Ware J. Random-effects models for longitudinal data. Biometrics 1982, 38:963-974.
14. 14. Kramer MS, Shapiro SH. Scientific challenges in the application of randomized trials. JAMA 1984, 52:2739-2745.
15. 15. Chalmers TC. The control of bias in clinical trials. In Clinical Trials. Issue and Approches. Edited by Shapiro SH, Louis TA. New York, Marcel Dekker, Inc.; 1983:115-127.
16. 16. Zelen M. The randomization and stratification of patients to clinial trials. J Chron Dis 1974, 27:365-375.
17. 17. Subbarao S, Schochetman C. Genetic variability of HIV-1. AIDS 1996, 10(suppl A):S13-S23.
18. 18. Lamhamedi-Cherradi S, Culmann-Penciolelli B, Guy B, et al. Different patterns of HIV-1-specific cytotoxic T-lymphocyle activity after primary infection. AIDS 1995, 9:421-426.
19. 19. Pantaleo C, Delarest JF, Schacker T, et al. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independant of the initial level of viremia. Proc Natl Acad Sci USA 1997, 94:254-258.
20. 20. Zaitseva M, Blauvelt A, Lee S, et al. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nature Med 1997, 3:1369-1375.
21. 21. Michael NL, Chang C, Louie LG, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med 1997, 3:338-340.
22. 22. Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 15:370-374.
23. 23. Schechter MT, Hogg RS, Aylward B, Craib KJ, Le TN, Montaner JS. Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care. J Clin Epidemiol 1994, 47:59-67.
24. 24. Bollinger RC, Brookmeyer RS, Mehendale SM, et al. Risk factors and clinical presentation of acute primary HIV infection in India. JAMA 1997, 278:2085-2089.
25. 25. Mellors JW, Kingsley LA, Rinaldo CR, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995, 122:573-579.